Montazeri Nima 13D/13G Filings for PharmaCyte Biotech, Inc. (PMCB)

Montazeri Nima 13D and 13G filings for PharmaCyte Biotech, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-07-29
4:34 pm
Sale		 2020-06-19 13D PharmaCyte Biotech, Inc.
PMCB		 Montazeri Nima 0
0.000%		 -61,459decrease
(Position Closed)		 Filing
2020-05-06
2:19 pm
Purchase		 2019-11-27 13D PharmaCyte Biotech, Inc.
PMCB		 Montazeri Nima 61,459
5.800%		 61,459increase
(New Position)		 Filing